Advances of the MAPK pathway in the treatment of spinal cord injury
Top Cited Papers
Open Access
- 17 June 2024
- journal article
- review article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 30 (6) , e14807
Abstract
Spinal cord injury (SCI) represents a complex pathology within the central nervous system (CNS), leading to severe sensory and motor impairments. It activates various signaling pathways, notably the mitogen‐activated protein kinase (MAPK) pathway. Present treatment approaches primarily focus on symptomatic relief, lacking efficacy in addressing the underlying pathophysiological mechanisms. Emerging research underscores the significance of the MAPK pathway in neuronal differentiation, growth, survival, axonal regeneration, and inflammatory responses post‐SCI. Modulating this pathway post‐injury has shown promise in attenuating inflammation, minimizing apoptosis, alleviating neuropathic pain, and fostering neural regeneration. Given its pivotal role, the MAPK pathway emerges as a potential therapeutic target in SCI management. This review synthesizes current knowledge on SCI pathology, delineates the MAPK pathway's characteristics, and explores its dual roles in SCI pathology and therapeutic interventions. Furthermore, it addresses the existing challenges in MAPK research in the context of SCI, proposing solutions to overcome these hurdles. Our aim is to offer a comprehensive reference for future research on the MAPK pathway and SCI, laying the groundwork for targeted therapeutic strategies.Keywords
Funding Information
- National Natural Science Foundation of China (82302677)
This publication has 150 references indexed in Scilit:
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Inflammation and apoptosis: linked therapeutic targets in spinal cord injuryTrends in Molecular Medicine, 2004
- Role of extracellular signal regulated kinases 1 and 2 in neuronal survivalEuropean Journal of Biochemistry, 2004
- Acute Spinal Cord Injury, Part I: Pathophysiologic MechanismsClinical Neuropharmacology, 2001
- Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and InflammationPhysiological Reviews, 2001
- ERK5 Is a Novel Type of Mitogen-Activated Protein Kinase Containing a Transcriptional Activation DomainMolecular and Cellular Biology, 2000
- Induction of Apoptosis Signal Regulating Kinase 1 (ASK1) after Spinal Cord Injury in RatsJournal of Neuropathology & Experimental Neurology, 1999
- Big Mitogen-activated Protein Kinase 1 (BMK1) Is a Redox-sensitive KinaseJournal of Biological Chemistry, 1996
- The MAPK signaling cascade.1995
- MAPKs: new JNK expands the groupTrends in Biochemical Sciences, 1994